Glutamate transporters: animal models to neurologic disease
- PMID: 15056453
- DOI: 10.1016/j.nbd.2003.12.007
Glutamate transporters: animal models to neurologic disease
Abstract
Glutamate is the primary excitatory amino acid neurotransmitter in the central nervous system and its activity is carefully modulated in the synaptic cleft by glutamate transporters. A number of glutamate transporters have been identified in the central nervous system and each has a unique physiologic property and distribution. Glutamate transporter dysfunction may either be an initiating event or part of a cascade leading to cellular dysfunction and ultimately cell death. Animal models of glutamate transporter dysfunction have revealed a significant role for these proteins in pathologic conditions such as neurodegenerative diseases, epilepsy, stroke, and central nervous system tumors. Recent work has focused on glutamate transporter biology in human diseases with an emphasis on how manipulation of these transporter proteins may lead to therapeutic interventions in neurologic disease.
Similar articles
-
[Role of glutamate transporters in astrocytes].Brain Nerve. 2007 Jul;59(7):677-88. Brain Nerve. 2007. PMID: 17663138 Review. Japanese.
-
Role of the GLT-1 subtype of glutamate transporter in glutamate homeostasis: the GLT-1-preferring inhibitor WAY-855 produces marginal neurotoxicity in the rat hippocampus.Eur J Neurosci. 2005 Jun;21(12):3217-28. doi: 10.1111/j.1460-9568.2005.04162.x. Eur J Neurosci. 2005. PMID: 16026460
-
[Structural and functional characteristics of glutamate transporters: how they are related to epilepsy and oxidative stress].Rev Neurol. 2007 Sep 16-30;45(6):341-52. Rev Neurol. 2007. PMID: 17899516 Review. Spanish.
-
Interactions between glutamate transporters and metabotropic glutamate receptors at excitatory synapses in the cerebellar cortex.Neurochem Int. 2004 Sep;45(4):537-44. doi: 10.1016/j.neuint.2003.11.007. Neurochem Int. 2004. PMID: 15186920
-
Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression.Nature. 2005 Jan 6;433(7021):73-7. doi: 10.1038/nature03180. Nature. 2005. PMID: 15635412
Cited by
-
Glial restricted precursor cells in central nervous system disorders: Current applications and future perspectives.Glia. 2021 Mar;69(3):513-531. doi: 10.1002/glia.23922. Epub 2020 Oct 14. Glia. 2021. PMID: 33052610 Free PMC article. Review.
-
Increased glutamate uptake in astrocytes via propentofylline results in increased tumor cell apoptosis using the CNS-1 glioma model.J Neurooncol. 2013 Aug;114(1):33-42. doi: 10.1007/s11060-013-1158-7. Epub 2013 May 22. J Neurooncol. 2013. PMID: 23695515 Free PMC article.
-
The potential roles of aquaporin 4 in amyotrophic lateral sclerosis.Neurol Sci. 2019 Aug;40(8):1541-1549. doi: 10.1007/s10072-019-03877-5. Epub 2019 Apr 13. Neurol Sci. 2019. PMID: 30980198 Review.
-
PACAP signaling to DREAM: a cAMP-dependent pathway that regulates cortical astrogliogenesis.Mol Neurobiol. 2009 Apr;39(2):90-100. doi: 10.1007/s12035-009-8055-2. Epub 2009 Feb 24. Mol Neurobiol. 2009. PMID: 19238593 Review.
-
Multi-_target action of β-alanine protects cerebellar tissue from ischemic damage.Cell Death Dis. 2022 Aug 29;13(8):747. doi: 10.1038/s41419-022-05159-z. Cell Death Dis. 2022. PMID: 36038575 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
